GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
基本信息
- 批准号:8271275
- 负责人:
- 金额:$ 1.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnimalsAnti-Inflammatory AgentsAnti-inflammatoryApoptosisBiologicalBone DiseasesBone MarrowBone necrosisCell physiologyCellsCicatrixClinicalClinical DataDebridementDefectDioxygenasesDiseaseDisease modelEngraftmentExhibitsFamily suidaeGingivaGoalsHumanIL17 geneIL6 geneImmuneImmunocompromised HostImmunologyImmunomodulatorsImmunosuppressionImmunosuppressive AgentsIn VitroInflammationInflammatoryInflammatory ResponseInfusion proceduresInjuryInterleukin-10Interleukin-17Interleukin-6JawKnowledgeMandibleMediatingMesenchymal Stem CellsModelingMolecularMouth DiseasesMucosal ImmunityMusNatural regenerationNecrosisNitric OxideOperative Surgical ProceduresOralOral cavityOral mucous membrane structurePathway interactionsPeriodontal LigamentPlayPropertyRegenerative MedicineRegulatory T-LymphocyteRoleSecondary toSkinSourceStem Cell ResearchStem cell transplantStem cellsT-LymphocyteTestingTherapeuticTissuesTooth SocketTumor Necrosis Factor Ligand Superfamily Member 6abstractingautocrinebasebisphosphonatebonechemokinecraniofacialcytokinegraft vs host diseaseimmune functionimmunoregulationin vivoindoleamineinjuredinjury and repairknock-downmedical specialtiesmouse modelnovelnovel therapeutic interventionoral tissueorofacialparacrinepre-clinicalpreventreconstructionregenerativerepairedrestorationself-renewalstem cell biologystem cell populationtissue regenerationtissue repair
项目摘要
PROJECT SUMMARY/ABSTRACT
A major roadblock in regenerative medicine is the ability to resolve disease-associated inflammation and to
optimize tissue regenerative capacity to prevent further tissue destruction secondary to inflammation or
scarring. Recently, a major breakthrough in mesenchymal stem cells (MSCs) research identifies an intrinsic
role of MSCs in immune-regulatory function. We have demonstrated that pro-inflammatory cytokines are
required for immunosuppressive function of MSCs through the concerted action of chemokines, and nitric
oxide, and that activated T cells can induce apoptosis of MSCs via the Fas/Fas L pathway. Our studies also
have revealed that the immunosuppressive property of skin derived MSCs were tightly regulated by the local
inflammatory niche mediated by the autocrine/paracrine IL17/IL6 axis, and therapeutic approaches targeting
these distinct niche components resulted in suppression of excessive scar formation. Based on these
observations, we explore the feasibility of isolating MSCs from human gingiva (hGMSCs), a unique oral tissue
that functions both as a biological mucosal barrier and a component of the oral mucosal immunity.
Interestingly, hGMSCs exhibit not only multipotent differentiation and self-renewal capacities but also possess
superior immunosuppressive effect as compared to bone marrow mesenchymal stem cells (BMMSC), by
inducing Tregs expansion and inhibiting Th17 cells, and consequently, suppress tissue destruction in our
inflammation-related tissue injury/osteonecrosis model induced by bisphosphonate (BRONJ).
We hypothesize that GMSCs are capable of playing dual roles in tissue repair including a protective role as an
immunomodulator to inhibit tissue injury and a tissue regeneration role through their multipotent differentiation
capacities.
In this application, our interdisciplinary team with advanced specialties in stem cell biology, immunology, tissue
repair/regeneration, and clinical therapies, proposes to elucidate the molecular mechanisms of inflammation-
related tissue injury/degeneration, and develop a novel therapeutic approach using GMSCs to suppress
inflammation and promote regeneration/reconstruction of diseased and injured oral and craniofacial tissues.
Our objective will be addressed using three integrated specific aims: 1) To further delineate stem cell
properties of hGMSCs at the single colony level; 2) To determine whether hGMSCs are capable of
immunomodulation and the underlying mechanisms; and 3) To explore the feasibility of targeting
GMSCs to reduce inflammation and promote tissue regeneration in animal models of inflammation-
related oral disorders/diseases.
This study will substantially extend current knowledge of the immunomodulatory functions of GMSCs and
provide critical pre-clinical data to test the feasibility and efficacy of novel therapeutic approach using GMSC to
harness inflammation and enhance regeneration of inflammation-related or injured orofacial tissues.
项目摘要/摘要
再生医学的一个主要障碍是解决与疾病相关的炎症和
优化组织再生能力,防止因炎症或其他原因继发的组织破坏
伤痕累累。最近,间充质干细胞(MSCs)研究的一项重大突破确定了一种内在的
骨髓间充质干细胞在免疫调节功能中的作用我们已经证明了促炎细胞因子是
趋化因子和一氧化氮协同作用对间充质干细胞免疫抑制功能的影响
激活的T细胞可通过Fas/Fas L途径诱导MSCs的凋亡。我们的研究也
已发现皮肤来源的MSCs的免疫抑制特性受到局部组织的严格调控
自分泌/旁分泌IL17/IL6轴介导的炎症生态位及其靶向治疗
这些独特的利基成分抑制了过度的疤痕形成。基于这些
通过观察,我们探索了从独特的口腔组织--人牙周组织中分离间充质干细胞的可行性。
这既是一种生物粘膜屏障,也是口腔粘膜免疫的一个组成部分。
有趣的是,hGMSCs不仅具有多向分化和自我更新的能力,而且还具有
优于骨髓间充质干细胞(BMMSC)的免疫抑制作用,通过
诱导Tregs扩张并抑制Th17细胞,从而抑制我们的组织破坏
双膦(BRONJ)诱导的炎症相关组织损伤/骨坏死模型。
我们假设GMSCs能够在组织修复中发挥双重作用,包括作为一种保护作用
免疫调节剂通过其多能分化抑制组织损伤和组织再生的作用
容量。
在这项应用中,我们的跨学科团队拥有干细胞生物学、免疫学、组织学等高级专业知识
修复/再生和临床治疗,建议阐明炎症的分子机制-
相关组织损伤/退变,并开发一种使用GMSCs抑制
发炎和促进病变和受伤的口腔和颅面组织的再生/重建。
我们的目标将通过三个综合的具体目标来实现:1)进一步描述干细胞
HGMSCs在单个集落水平的特性;2)确定hGMSCs是否有能力
免疫调节及其机制;3)探讨靶向治疗的可行性
GMSCs在炎症动物模型中减轻炎症并促进组织再生-
相关的口腔疾病/疾病。
这项研究将大大扩展目前对GMSCs免疫调节功能的了解,并
提供关键的临床前数据,以测试使用GMSC的新治疗方法的可行性和有效性
治疗炎症并促进炎症相关或受伤的口腔组织的再生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anh D Le其他文献
Anh D Le的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anh D Le', 18)}}的其他基金
Targeted inhibition of eIF5Ahpu suppresses tumor growth and M2-like TAM polarization in oral cancer
靶向抑制 eIF5Ahpu 可抑制口腔癌中的肿瘤生长和 M2 样 TAM 极化
- 批准号:
10573290 - 财政年份:2022
- 资助金额:
$ 1.76万 - 项目类别:
Targeted inhibition of eIF5Ahpu suppresses tumor growth and M2-like TAM polarization in oral cancer
靶向抑制 eIF5Ahpu 可抑制口腔癌中的肿瘤生长和 M2 样 TAM 极化
- 批准号:
10441837 - 财政年份:2022
- 资助金额:
$ 1.76万 - 项目类别:
Therapeutic Potential of Gingival mesenchymal Stem Cell-derived Extracellular Vesicles Enriched with MFG-E8 in Peripheral Nerve Regeneration
富含 MFG-E8 的牙龈间充质干细胞来源的细胞外囊泡在周围神经再生中的治疗潜力
- 批准号:
10180941 - 财政年份:2020
- 资助金额:
$ 1.76万 - 项目类别:
Therapeutic Potential of Gingival mesenchymal Stem Cell-derived Extracellular Vesicles Enriched with MFG-E8 in Peripheral Nerve Regeneration
富含 MFG-E8 的牙龈间充质干细胞来源的细胞外囊泡在周围神经再生中的治疗潜力
- 批准号:
10042927 - 财政年份:2020
- 资助金额:
$ 1.76万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
7728606 - 财政年份:2009
- 资助金额:
$ 1.76万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
7851425 - 财政年份:2009
- 资助金额:
$ 1.76万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
8070529 - 财政年份:2009
- 资助金额:
$ 1.76万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
8466720 - 财政年份:2009
- 资助金额:
$ 1.76万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
8600475 - 财政年份:2009
- 资助金额:
$ 1.76万 - 项目类别:
BOWMAN-BIRK INHIBITOR CONCENTRATE & ORAL LEUKOPLAKIA: PHASE IIB TRIAL (UNIVER
BOWMAN-BIRK 抑制剂浓缩液
- 批准号:
7716696 - 财政年份:2008
- 资助金额:
$ 1.76万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 1.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists